Peripheral Nerve Stimulation and Peripheral Nerve Field Stimulation - (0539) — MM 0539 | CIGNA Coverage Update

Cigna modified MM 0539 covering peripheral nerve stimulation and peripheral nerve field stimulation, effective September 26, 2025. Here's what billing teams need to know.

Cigna Healthcare updated Coverage Policy MM 0539 in the MM 0539 Cigna system, addressing implantable peripheral nerve stimulation (PNS) and peripheral nerve field stimulation (PNFS) for pain conditions. The five affected CPT codes — 64555, 64575, 64590, 64596, and 64597 — are all designated as not medically necessary for the treatment of acute conditions under this revised policy. If your practice bills these codes against Cigna commercial plans, this change has direct reimbursement exposure starting September 26, 2025.

Quick-Reference Table

Cigna Peripheral Nerve Stimulation Coverage Criteria and Medical Necessity Requirements 2025

The core issue in this coverage policy is the medical necessity designation for all five procedural codes. Cigna classifies CPT 64555 (percutaneous implantation of neurostimulator electrode array, peripheral nerve), CPT 64575 (open implantation of neurostimulator electrode array, peripheral nerve), and CPT 64590 (insertion or replacement of peripheral or gastric neurostimulator pulse generator or receiver) as not medically necessary for the treatment of acute pain conditions.

The same not medically necessary designation applies to CPT 64596 and CPT 64597 — both covering insertion or replacement of a percutaneous electrode array with an integrated neurostimulator for peripheral nerve. These two codes are newer additions to the peripheral nerve stimulation billing landscape, and their explicit inclusion here signals that Cigna is drawing a firm line against acute-indication claims across the full code set.

The real issue is what "acute" means in practice. Cigna's coverage policy draws a distinction between acute pain treatment — which it considers not medically necessary — and presumably chronic or specific qualifying diagnoses. But the policy summary doesn't spell out a detailed list of covered chronic indications, which creates ambiguity for billing teams trying to determine whether a given patient's diagnosis clears the bar for reimbursement.

If you're billing PNS or PNFS for chronic pain, complex regional pain syndrome, or other non-acute diagnoses, that may still be supportable under this policy. But "may" is doing a lot of work there. Talk to your compliance officer before the effective date if you have volume on these codes and aren't certain where your patient mix lands.

One important carve-out: Cigna explicitly routes headache, occipital neuralgia, and trigeminal neuralgia cases to a separate coverage policy — not MM 0539. If your practice treats those conditions with electrical stimulation and bills through this code set, stop and pull the correct policy before submitting those claims.

Prior authorization requirements for PNS procedures under Cigna plans vary by plan type, but given the not medically necessary designation for acute conditions, expect scrutiny on any prior auth request that doesn't clearly document a chronic, qualifying diagnosis. Weak documentation at the prior authorization stage is the fastest path to a claim denial here.

Cigna Peripheral Nerve Stimulation Exclusions and Non-Covered Indications

All five codes in this policy carry the same exclusion: treatment of acute pain conditions. That's a broad brush. Cigna doesn't define a specific acute timeframe (30 days? 90 days?) in the available policy summary, which is a gap your billing team should flag.

The practical risk is this: if a patient presents with a recent injury or post-surgical pain and a provider orders PNS or PNFS, those claims are landing in denied territory under MM 0539. It doesn't matter which of the five codes you bill. The not medically necessary designation applies across the entire procedural code set for acute indications.

This is not a situation where switching codes saves you. CPT 64555 versus 64596 versus 64597 — Cigna treats them the same way for acute pain. The denial risk is uniform.

Coverage Indications at a Glance

Cigna Peripheral Nerve Stimulation Billing Guidelines and Action Items 2025

The effective date is September 26, 2025. That's your hard deadline. Here's what to do before it.

CPT, HCPCS, and ICD-10 Codes for Peripheral Nerve Stimulation Under MM 0539

The policy data provides five CPT codes. No HCPCS codes are listed in this policy. No ICD-10-CM codes are specified in the available policy data.

Not Covered CPT Codes for Acute Pain Indications

No covered CPT codes are listed in this policy for PNS/PNFS. The coverage policy's scope is defining what is not medically necessary — specifically the acute pain indication — rather than establishing a positive covered list. Peripheral nerve stimulation billing for non-acute, qualifying diagnoses may still be supportable, but you'll need to document against criteria not fully enumerated in this policy summary. That's a gap worth escalating to your compliance officer if PNS volume is material to your practice.

No ICD-10-CM diagnosis codes are specified in the available MM 0539 policy data.